This short non-coding microRNA promotes metastasis-related molecular properties in MDA-MB-231 aggressive breast cancer cells, by targeting sclerostin and secreted frizzled-related protein 2 (SFRP2), which greatly enhances Wnt signaling. This evidence concerns the gene SOST and breast cancer.